Allergy Therapeutics plc (AIM:AGY)

Revenue by Segment

Financials in millions GBP. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018	Jun 30, 2017	Jun 30, 2016
Sale of a Range of Pharmaceutical Products	55.04M	55.20M	59.59M	72.77M	84.33M
Total	55.04M	55.20M	59.59M	72.77M	84.33M

Revenue by Geography

Financials in millions GBP. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018	Jun 30, 2017	Jun 30, 2016
Germany	26.69M	27.30M	31.76M	42.58M	53.80M
Austria	5.26M	4.95M	4.90M	5.23M	5.60M
Netherlands	3.96M	4.06M	4.02M	4.28M	4.17M
Switzerland	2.34M	2.86M	2.84M	3.30M	3.14M
Italy	2.87M	3.07M	3.05M	3.40M	3.97M
Spain	9.60M	8.88M	9.38M	8.87M	8.42M
Other Southern Europe	196.00K	368.00K	396.00K	562.00K	532.00K
Inter Segment Revenue	-30.63M	-30.41M	-28.73M	-39.37M	-53.98M
Rest of World (Including UK)	34.78M	34.12M	31.98M	43.92M	58.68M
Total	55.04M	55.20M	59.59M	72.77M	84.33M

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 9, 2026

Data Sources Report a data error